Back to Search
Start Over
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents : A retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
- Source :
- Annals of hematology 100(4), 959-968 (2021). doi:10.1007/s00277-020-04321-x, Annals of Hematology
- Publication Year :
- 2021
-
Abstract
- Annals of hematology 100(4), 959-968 (2021). doi:10.1007/s00277-020-04321-x<br />Published by Springer, Berlin ; Heidelberg ; New York
- Subjects :
- Oncology
medicine.medical_specialty
Myeloid
medicine.medical_treatment
Azacitidine
Medizin
Decitabine
Salvage therapy
Hypomethylating agents
Hematopoietic stem cell transplantation
Neutropenia
Venetoclax
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Internal medicine
Medicine
ddc:610
Relapse
Hematology
business.industry
General Medicine
medicine.disease
medicine.anatomical_structure
chemistry
030220 oncology & carcinogenesis
Allogeneic hematopoietic stem cell transplantation
Original Article
DLI
business
030215 immunology
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Annals of hematology 100(4), 959-968 (2021). doi:10.1007/s00277-020-04321-x, Annals of Hematology
- Accession number :
- edsair.doi.dedup.....607932063681b61bba7955d70f3233d3